The UAB-Related International Travel Policy has been revised to address changes in the U.S. Department of State's approach to travel advisories, as well as changes in administrative responsibility for review and management of risks associated with UAB-related international travel.  The associated International Travel Guidelines and Resources for UAB Employees and Students has also been revised to reflect the relevant updates.

UAB's revised Export Control Policy has been updated to provide additional definitions and to reinforce responsibilities of UAB faculty, staff, and students for compliance with federal laws and regulations governing certain exports of items or services with desinations outside of the U.S. or to foreign persons within the U.S.  The revised policy also reflects changes in UAB organizational responsibility for managing export control program activities from the Office of Compliance & Risk Assurance to the Office of Research.

These policy revisions are effective August 1, 2021.

Beginning in August 2013, the Federal Open Payments Law (also known as the Physician Payment Sunshine Act) requires pharmaceutical and medical device/supply companies to report to Centers for Medicare & Medicaid Services both direct and indirect transfers of value to certain providers and teaching hospitals. See the Office of Compliance & Risk Assurance Open Payments Law Fact Sheet for guidance and more information on this important federal law.

The new UAB Enterprise Conflict of Interest and Conflict of Commitment Policy is now available. Since August 2012 when this enterprise-wide policy was last updated, there have been significant changes in public expectations for transparency, research regulatory environment, and approaches UAB’s peer and aspirant peer institutions are taking to identify and manage conflicts of interest and commitment.  To respond to the current landscape, a committee of representatives from academic and administrative offices across the University and UAB Health System collaborated to review and edit the document to address these concerns and to provide greater clarity in requirements, restrictions, and processes established in this overarching governing document. The result is a new policy that:

The UAB Enterprise Risk Council has approved the new UAB Enterprise Code of Conduct with an effective date of October 1, 2011.  The code is designed as a tool to help guide ethical decision-making by UAB community members  in the UAB Enterprise - including the University, UAB Medicine, and UAB foundations, alumni associations, and operating organizations.  The UAB Enterprise Code of Conduct does NOT represent a change in policy or a response to a particular problem or set of circumstances.  Rather, it expands on and combines the Research Code of Conduct, in place in the University for a number of years, with the various codes of conduct of UAB's health-related entities. 

University faculty and staff will be learning more about the UAB Enterprise Code of Conduct from leadership in the coming months.  For more information, visit the Code of Conduct.